Government & The Law
The peptide fight in Washington and the states — primary sources, date-stamped.
Peptides are being decided right now — in an FDA advisory committee, in a Federal Register docket, and in fifty state capitals. This section tracks it from primary sources: the Federal Register, FDA documents, and hearing recordings.
The live moment: On October 30, 2026, HHS published an enforcement-discretion policy covering six peptides. Public comments close November 13, 2026. Read the explainer before you read anyone’s headline:
- Six Peptides, One Policy: What HHS Actually Did on October 30
- Our Legal Mandate — what the law is, as we understand it, and the publishing rules we follow because of it
- 503A, 503B, and the Three Lists Nobody Explains
- The State Patchwork: A Federal Win Is Not State Permission
- The $328 Million Question: Peptide Imports from China, Counted Honestly
The $328 Million Question: Peptide Imports from China, Counted Honestly
Two numbers describe the peptide trade with China — a customs total that mixes legal and gray trade, and a crypto trail that isolates the gray market. Both, with their definitions attached.
Go →503A, 503B, and the Three Lists Nobody Explains
The compounding framework in plain English — because every peptide headline depends on it.
Go →Our Legal Mandate
What the law is, as this site understands it — and the publishing rules we follow because of it. Date-stamped November 7, 2026.
Go →Six Peptides, One Policy: What HHS Actually Did on October 30, 2026
The Federal Register document behind the headlines — what it says, what it does not say, and the November 13 comment deadline.
Go →The State Patchwork: A Federal Win Is Not State Permission
Why 'available by prescription' is true or false depending on your zip code.
Go →